
Chondroitin Sulfate
Chondroitin sulfate is a glycosaminoglycan considered as a symptomatic slow-acting drug for osteoarthritis (SYSADOA). The SYSADOA status suggested a pain relief and increased joint mobility after a relative long regular administration, as well as a long-lasting effect after the end of the treatment. Chondroitin sulfate is composed of alternating 1,3-N-acetyl-β-d-galactosamine and 1,4-β-d-glucuronic acid units which bear 4-O- and/or 6-O-sulfations at the N-acetylgalactosamine units disposed of in specific patterns. Depending on the predominating disaccharide unit, it will present different biological activities. Chondroitin sulfate is sold as an OTC dietary supplement in North America and it is a prescription drug under the EMA in Europe. — DrugBank
- IUPAC 名称
- (2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-sulfooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
- 分子式
- C13H21NO15S
- 分子量
- 463.37 g/mol
- 精确质量
- 463.06319014 Da
- XLogP3
- -4.8
- 拓扑极性表面积
- 267.0 Ų
- 氢键供体
- 8
- 氢键受体
- 15
- 共价单元
- 1
- 已定义的立体中心
- 10
又称
另有 16 个已报告名称
外部数据库标识符
- ChEMBL:CHEMBL5266347
- EPA DTXSID:DTXSID601017238
- PubMed:5601
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。